The role of delayed bone age in the evaluation of stature and bone health in glucocorticoid treated patients with Duchenne muscular dystrophy.
Autorzy:
Annexstad EJ; 1Department of Neurology, Unit for Congenital and Inherited Neuromuscular Disorders, Oslo University Hospital, PoBox 4950, Nydalen, 0424 Oslo, Norway.; 2Faculty of Medicine, University of Oslo, Oslo, Norway.; 3Department of Clinical Neurosciences for Children, Oslo University Hospital, Oslo, Norway.; 8Children's Department, Ostfold Hospital Trust, Sarpsborg, Norway. Bollerslev J; 4Department of Endocrinology, Section of Specialized Endocrinology, Oslo University Hospital Rikshospitalet, Oslo, Norway.; 2Faculty of Medicine, University of Oslo, Oslo, Norway. Westvik J; 5Department of Radiology, Section for Paediatric Radiology, Oslo University Hospital Rikshospitalet, Oslo, Norway. MyhreAG; Frambu Resource Centre for Rare Disorders, Siggerud, Norway. Godang K; 4Department of Endocrinology, Section of Specialized Endocrinology, Oslo University Hospital Rikshospitalet, Oslo, Norway. Holm I; 2Faculty of Medicine, University of Oslo, Oslo, Norway.; 7Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway. Rasmussen M; 1Department of Neurology, Unit for Congenital and Inherited Neuromuscular Disorders, Oslo University Hospital, PoBox 4950, Nydalen, 0424 Oslo, Norway.; 3Department of Clinical Neurosciences for Children, Oslo University Hospital, Oslo, Norway.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies